RxDoctor Payments Data

Timothy Pflederer, MD

Nephrology · Peoria, ILNPI 1154451573

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,293 of the $46,095 with a category attached, or 87.4%. Bard Peripheral Vascular, Inc. accounts for 91.8% of it on its own, with 3 other manufacturers making up the rest. Among nephrology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,095in general payments, 2019–2025

Across 36 payments — averaging $1280.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$42K
  • Nxstage Medical, Inc.$3K
  • Sonavex, Inc.$314
  • Vifor Pharma, Inc.$14
$5,680in research payments, 2019–2025

Across 3 payments — averaging $1893.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$6K

What the payments were for

  • Consulting fees$40,29387%
  • Speaking & faculty fees$3,3507%
  • Grants$7202%
  • Travel & lodging$1,3613%
  • Food & beverage$3711%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,095 in reported general payments places this provider in the 95th percentile of 524 nephrology providers in Illinois.

See all nephrology providers in Illinois

Medicare billing

Part B allowed, 2024
$28,046
Medicare patients
102
Services billed
206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin36$31,711
FarxigaDapagliflozin Propanediol21$11,874
Losartan Potassium48$357
Labetalol Hcl12$315
Calcitriol19$291
Amlodipine Besylate50$259
Lisinopril48$207
Allopurinol20$168
Hydralazine Hcl14$138
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim36$106
Furosemide32$104
Omeprazole14$77
Carvedilol11$57
Fenofibrate11$34
Hydrochlorothiazide11$14

Paid to pharmacies, not to this prescriber.

Other nephrology in Peoria

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →